Osteopontin deficiency dampens the pro-atherogenic effect of uraemia

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Osteopontin deficiency dampens the pro-atherogenic effect of uraemia. / Pedersen, Tanja Xenia; Madsen, Marie; Nielsen, Nanna Maria Junker; Christoffersen, Christina; Vikeså, Jonas; Bro, Susanne; Hultgårdh-Nilsson, Anna; Nielsen, Lars Bo.

I: Cardiovascular Research, Bind 98, Nr. 3, 01.06.2013, s. 352-9.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Pedersen, TX, Madsen, M, Nielsen, NMJ, Christoffersen, C, Vikeså, J, Bro, S, Hultgårdh-Nilsson, A & Nielsen, LB 2013, 'Osteopontin deficiency dampens the pro-atherogenic effect of uraemia', Cardiovascular Research, bind 98, nr. 3, s. 352-9. https://doi.org/10.1093/cvr/cvt049

APA

Pedersen, T. X., Madsen, M., Nielsen, N. M. J., Christoffersen, C., Vikeså, J., Bro, S., ... Nielsen, L. B. (2013). Osteopontin deficiency dampens the pro-atherogenic effect of uraemia. Cardiovascular Research, 98(3), 352-9. https://doi.org/10.1093/cvr/cvt049

Vancouver

Pedersen TX, Madsen M, Nielsen NMJ, Christoffersen C, Vikeså J, Bro S o.a. Osteopontin deficiency dampens the pro-atherogenic effect of uraemia. Cardiovascular Research. 2013 jun 1;98(3):352-9. https://doi.org/10.1093/cvr/cvt049

Author

Pedersen, Tanja Xenia ; Madsen, Marie ; Nielsen, Nanna Maria Junker ; Christoffersen, Christina ; Vikeså, Jonas ; Bro, Susanne ; Hultgårdh-Nilsson, Anna ; Nielsen, Lars Bo. / Osteopontin deficiency dampens the pro-atherogenic effect of uraemia. I: Cardiovascular Research. 2013 ; Bind 98, Nr. 3. s. 352-9.

Bibtex

@article{f95cec699d344c289cadb9af04325b40,
title = "Osteopontin deficiency dampens the pro-atherogenic effect of uraemia",
abstract = "Uraemia is a strong risk factor for cardiovascular disease. Osteopontin (OPN) is highly expressed in aortas of uraemic apolipoprotein E knockout (E KO) mice. OPN affects key atherogenic processes, i.e. inflammation and phenotypic modulation of smooth muscle cells (SMCs). We explored the role of OPN on vascular pathology in uraemic mice.",
author = "Pedersen, {Tanja Xenia} and Marie Madsen and Nielsen, {Nanna Maria Junker} and Christina Christoffersen and Jonas Vikes{\aa} and Susanne Bro and Anna Hultg{\aa}rdh-Nilsson and Nielsen, {Lars Bo}",
year = "2013",
month = "6",
day = "1",
doi = "10.1093/cvr/cvt049",
language = "English",
volume = "98",
pages = "352--9",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "3",

}

RIS

TY - JOUR

T1 - Osteopontin deficiency dampens the pro-atherogenic effect of uraemia

AU - Pedersen, Tanja Xenia

AU - Madsen, Marie

AU - Nielsen, Nanna Maria Junker

AU - Christoffersen, Christina

AU - Vikeså, Jonas

AU - Bro, Susanne

AU - Hultgårdh-Nilsson, Anna

AU - Nielsen, Lars Bo

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Uraemia is a strong risk factor for cardiovascular disease. Osteopontin (OPN) is highly expressed in aortas of uraemic apolipoprotein E knockout (E KO) mice. OPN affects key atherogenic processes, i.e. inflammation and phenotypic modulation of smooth muscle cells (SMCs). We explored the role of OPN on vascular pathology in uraemic mice.

AB - Uraemia is a strong risk factor for cardiovascular disease. Osteopontin (OPN) is highly expressed in aortas of uraemic apolipoprotein E knockout (E KO) mice. OPN affects key atherogenic processes, i.e. inflammation and phenotypic modulation of smooth muscle cells (SMCs). We explored the role of OPN on vascular pathology in uraemic mice.

U2 - 10.1093/cvr/cvt049

DO - 10.1093/cvr/cvt049

M3 - Journal article

C2 - 23455547

VL - 98

SP - 352

EP - 359

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 3

ER -

ID: 45810489